CCIA
RVNC
Campbell & Co Investment Adviser’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-100,907
| Closed | -$1.16M | – | 1399 |
|
|
2023
Q3 | $1.16M | Buy |
100,907
+85,074
| +537% | +$976K | 0.14% | 222 |
|
|
2023
Q2 | $401K | Buy |
+15,833
| New | +$401K | 0.07% | 529 |
|
|
2023
Q1 | – | Sell |
-28,390
| Closed | -$524K | – | 1073 |
|
|
2022
Q4 | $524K | Buy |
+28,390
| New | +$524K | 0.13% | 287 |
|
|
2021
Q3 | – | Sell |
-12,600
| Closed | -$373K | – | 815 |
|
|
2021
Q2 | $373K | Buy |
+12,600
| New | +$373K | 0.15% | 244 |
|
|
2019
Q2 | – | Sell |
-10,776
| Closed | -$170K | – | 738 |
|
|
2019
Q1 | $170K | Buy |
+10,776
| New | +$170K | 0.08% | 467 |
|